Evidence map›Paper›PMID 33564680›Full record

ReviewBioMed research international2021

Effect of Statins on Platelet Activation and Function: From Molecular Pathways to Clinical Effects.

Antonio Nenna, Francesco Nappi, Mario Lusini, Umberto Maria Satriano, Davide Schilirò, Cristiano Spadaccio, Massimo Chello

Open access · hybridFull text readReview
In one paragraph

Review in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Platelets and Thrombotic Antiphospholipid Syndrome.Journal of clinical medicine · 2024
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Antonio NennaCardiovascular Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.ORCID https://orcid.org/0000-0002-4069-6781
Francesco NappiCardiac Surgery, Centre Cardiologique du Nord de Saint Denis, Paris, France.ORCID https://orcid.org/0000-0002-9705-5360
Mario LusiniCardiovascular Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.
Umberto Maria SatrianoCardiovascular Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.
Davide SchiliròCardiovascular Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.
Cristiano SpadaccioCardiac Surgery, Golden Jubilee National Hospital, Glasgow, UK.ORCID https://orcid.org/0000-0002-1672-7576
Massimo ChelloCardiovascular Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.ORCID https://orcid.org/0000-0001-8178-7068
Università Campus Bio-Medico · ITCentre Cardiologique du Nord · FRGolden Jubilee National Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeStatins are a class of drugs widely used in clinical practice for their lipid-lowering and pleiotropic effects. In recent years, a correlation between statins and platelet function has been unveiled in the literature that might introduce new therapeutic indications for this class of drugs. This review is aimed at summarizing the mechanisms underlying statin-platelet interaction in the cardiologic scenario and building the basis for future in-depth studies.

methodsWe conducted a literature search through PubMed, Embase, EBSCO, Cochrane Database of Systematic Reviews, and Web of Science from their inception to June 2020.

resultsMany pathways could explain the interaction between statins and platelets, but the specific effect depends on the specific compound. Some could be mediated by enzymes that allow the entry of drugs into the cell (OATP2B1) and others by enzymes that mediate their activation (PLA2, MAPK, TAX2, PPARs, AKT, and COX-1), recruitment and adhesion (LOX-1, CD36, and CD40L), or apoptosis (BCL2). Statins also appear to have a synergistic effect with aspirin and low molecular weight heparins. Surprisingly, they seem to have an antagonistic effect with clopidogrel.

conclusionThere are many pathways potentially responsible for the interactions between statins and platelets. Their effect appears to be closely related, and each single effect can be barely measured. Also, the same compound might have complex downstream signaling with potentially opposite effects, i.e., beneficial or deleterious. The multiple clinical implications that can be derived as a result of this interaction, however, represent an excellent reason to develop future in-depth studies.

Indexed as

AspirinBlood PlateletsCD36 AntigensHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHyperlipidemiasOrganic Anion TransportersPlatelet ActivationSignal TransductionAspirinCD36 AntigensHydroxymethylglutaryl-CoA Reductase InhibitorsOrganic Anion TransportersSLCO2B1 protein, human

Identifiers

PMID33564680
PMCPMC7850835
OpenAlexW3124828965

What Socratic holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.